AMANDA STRATHMANN: Open Payments
NPI 1144702945 · BOONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 27 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $144 · 2025 $1,774
Travel & lodging: $1,030Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $1,327 |
| Vanda Pharmaceuticals Inc. | 2 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
Products named: FANAPT, REXULTI, Wegovy, TRINTELLIX, PREVNAR 20, MOUNJARO, CAPLYTA, Auvelity.
Industry payments across IN — which companies pay providers there.
